Updated 04:19 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,873.60 -0.33% CL 88.49 -0.08% BTC 64,896.46 +1.20%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,874 −0.33% BTC $64,896 +1.20% VIX 19.30 +3.21% latest tape · as of 04:19 UTC
The Screen · Basic Materials · Other Industrial Metals & Mining

Brazil Potash Corp.

GRO · NYSE American · USD · Market cap $128M · 36 employees

Brazil Potash Corp.

Not yet scored
1.65 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price1.65 USD at the 13 Nov 2026 close
  • Fair valueUnder review: our model's value is 2.84x the price, above our 1.35x limit.
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenNot yet scored
  • OptionsOpen interest leans heavily to calls (put/call 0.25)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-13).

Current read
Distribution ?
Screened · screened 2026-11-13
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical screen not yet scored
Price1.65 USD
Fair valueUnder review
Ethical score94.0/100
Our investment reviews on this name
2026-11-11Read Distribution1.85-10.8% to today ✓Markdown gives way to Distribution after a 20% slide in 6 weeks
2026-10-02Read Markdown2.32-28.9% to today ✓Accumulation gives way to Markdown first Markdown read since July
2026-08-31Read Accumulation2.26-27.0% to today Markdown gives way to Accumulation with volume flow in agreement
2026-07-02Read Markdown2.20-25.0% to today ✓First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Brazil Potash Corp. holds its Distribution at $1.65. The statistical read favours the sellers, held for 138 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 138 days
Price at the screen$1.65
ValuationN/A trailing · -7.39 forward price to earnings
Values screenNot scored · score 94.0
The Workings

Five Screens, Shown in Full

This security has not been fully scored against the values screen yet.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 0.31% Below 33% Interest-bearing debt is just 0.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 15.53% Below 33% Cash held in interest-bearing accounts and securities is 15.5% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

The Read, in Plain English

Brazil Potash clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

2026-10-25

Brazil Potash clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

2026-09-24 Clears

Brazil Potash clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.

Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Our model's value is 2.84x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

The Street's Range
3.50Street low 5.00Street average 12.00Street high 1.65Price

Third-party analyst targets. The average target sits +203% from the screen price.

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E-7.4x
EPS, trailing-0.54
EPS, forward-0.28
Profit margin0.0%currently unprofitable
Return on equity-15.8%not currently earning a positive return on equity
FCF yield-10.83%
Debt to equity0.23minimal debt: a conservative balance sheet
Current ratio42.20comfortably covers its short-term bills
Short interest, float0.01%
52-week range1.86 - 3.99
Market cap$128M
Employees36

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Canada and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

GRO trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-11 Distribution · changed $1.85 +8.2% Entry 11

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-11-04 Markdown $1.71 -17.4% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 17.4% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-10-28 Markdown $2.07 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-10-21 Markdown $2.07 -3.3% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-10-14 Markdown $2.14 -7.8% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.8% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-10-02 Markdown · changed $2.32 +2.7% Entry 6

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-08-31 Accumulation · changed $2.26 +3.7% Entry 5

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-07-31 Markdown $2.18 -0.9% Entry 4

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-07-18 Markdown $2.20 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-07-03 Markdown $2.20 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on GRO

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in GRO's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · GRO
DateInsiderTitleTypeSharesValue
2025-11-12 SENTIENT EXECUTIVE GP III LIMITED Beneficial Owner of more than 10% of a Class of Security 3,863,872 $7,727,744

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming GRO
DatePoliticianPartyTypeAmount
2026-10-22 Chuck Fleischmann Republican sell 1K–15K
2026-10-22 Chuck Fleischmann Republican buy 1K–15K
2026-10-20 Dave McCormick Republican buy 250K–500K
2026-10-20 Dave McCormick Republican buy 250K–500K
2026-10-20 Dave McCormick Republican buy 250K–500K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $2.69 -21.9% · $781 -21.9%
2 months $3.07 -31.6% · $684 -31.6%
3 months $3.65 -42.5% · $575 -42.5%
6 months $2.19 -4.1% · $959 -4.1%
1 year $2.02 +4.0% · $1,040 +4.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever GRO does next, these words stay.

Brazil Potash Corp. · GRO · Distribution · $1.65
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.